Global Radiopharmaceuticals Market Insights, Forecast To 2025

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic

Region : 02011075675 | Price: 2900 | Report ID: 02011075675
Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

In the last several years, global market of Radiopharmaceuticals developed year by year, with an average growth rate of 8.02% for the sales. In 2016, global revenue of Radiopharmaceuticals is nearly 4546 M USD; the sale is about 130 M Dose.

The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The proportion of Diagnostic Radioisotopes in 2016 is about 89.22%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.

Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 62.63%.

The global Radiopharmaceuticals market is valued at 4900 million US$ in 2018 and will reach 8410 million US$ by the end of 2025, growing at a CAGR of 8.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Radiopharmaceuticals market based on company, product type, end user and key regions.

This report studies the global market size of Radiopharmaceuticals in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Radiopharmaceuticals in these regions.

This research report categorizes the global Radiopharmaceuticals market by top players/brands, region, type and end user. This report also studies the global Radiopharmaceuticals market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

Bracco Imaging




Triad Isotopes


IBA Group

GE Healthcare

China Isotope & Radiation

Jubilant Pharma

Eli Lilly

Advanced Accelerator Applications




Market size by Product

Diagnostic Radioisotopes

Therapeutic Radioisotopes

Market size by End User




Market size by Region

North America

United States







South Korea















Central & South America


Rest of Central & South America

Middle East & Africa

GCC Countries



South Africa

The study objectives of this report are:

To study and analyze the global Radiopharmaceuticals market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

To understand the structure of Radiopharmaceuticals market by identifying its various subsegments.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

Focuses on the key global Radiopharmaceuticals companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

To project the value and sales volume of Radiopharmaceuticals submarkets, with respect to key regions.

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Radiopharmaceuticals are as follows:

History Year: 2014-2018

Base Year: 2018

Estimated Year: 2019

Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Dose). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Radiopharmaceuticals market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage

1.1 Radiopharmaceuticals Product

1.2 Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Radiopharmaceuticals Market Size Growth Rate by Product

1.4.2 Diagnostic Radioisotopes

1.4.3 Therapeutic Radioisotopes

1.5 Market by End User

1.5.1 Global Radiopharmaceuticals Market Size Growth Rate by End User

1.5.2 Oncology

1.5.3 Cardiology

1.5.4 Other

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Radiopharmaceuticals Market Size

2.1.1 Global Radiopharmaceuticals Revenue 2014-2025

2.1.2 Global Radiopharmaceuticals Sales 2014-2025

2.2 Radiopharmaceuticals Growth Rate by Regions

2.2.1 Global Radiopharmaceuticals Sales by Regions

2.2.2 Global Radiopharmaceuticals Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Radiopharmaceuticals Sales by Manufacturers

3.1.1 Radiopharmaceuticals Sales by Manufacturers

3.1.2 Radiopharmaceuticals Sales Market Share by Manufacturers

3.1.3 Global Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)

3.2 Radiopharmaceuticals Revenue by Manufacturers

3.2.1 Radiopharmaceuticals Revenue by Manufacturers (2014-2019)

3.2.2 Radiopharmaceuticals Revenue Share by Manufacturers (2014-2019)

3.3 Radiopharmaceuticals Price by Manufacturers

3.4 Radiopharmaceuticals Manufacturing Base Distribution, Product Types

3.4.1 Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Radiopharmaceuticals Product Type

3.4.3 Date of International Manufacturers Enter into Radiopharmaceuticals Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Radiopharmaceuticals Sales by Product

4.2 Global Radiopharmaceuticals Revenue by Product

4.3 Radiopharmaceuticals Price by Product

5 Breakdown Data by End User

5.1 Overview

5.2 Global Radiopharmaceuticals Breakdown Data by End User

6 North America

6.1 North America Radiopharmaceuticals by Countries

6.1.1 North America Radiopharmaceuticals Sales by Countries

6.1.2 North America Radiopharmaceuticals Revenue by Countries

6.1.3 United States

6.1.4 Canada

6.1.5 Mexico

6.2 North America Radiopharmaceuticals by Product

6.3 North America Radiopharmaceuticals by End User

7 Europe

7.1 Europe Radiopharmaceuticals by Countries

7.1.1 Europe Radiopharmaceuticals Sales by Countries

7.1.2 Europe Radiopharmaceuticals Revenue by Countries

7.1.3 Germany

7.1.4 France

7.1.5 UK

7.1.6 Italy

7.1.7 Russia

7.2 Europe Radiopharmaceuticals by Product

7.3 Europe Radiopharmaceuticals by End User

8 Asia Pacific

8.1 Asia Pacific Radiopharmaceuticals by Countries

8.1.1 Asia Pacific Radiopharmaceuticals Sales by Countries

8.1.2 Asia Pacific Radiopharmaceuticals Revenue by Countries

8.1.3 China

8.1.4 Japan

8.1.5 Korea

8.1.6 India

8.1.7 Australia

8.1.8 Indonesia

8.1.9 Malaysia

8.1.10 Philippines

8.1.11 Thailand

8.1.12 Vietnam

8.1.13 Singapore

8.2 Asia Pacific Radiopharmaceuticals by Product

8.3 Asia Pacific Radiopharmaceuticals by End User

9 Central & South America

9.1 Central & South America Radiopharmaceuticals by Countries

9.1.1 Central & South America Radiopharmaceuticals Sales by Countries

9.1.2 Central & South America Radiopharmaceuticals Revenue by Countries

9.1.3 Brazil

9.2 Central & South America Radiopharmaceuticals by Product

9.3 Central & South America Radiopharmaceuticals by End User

10 Middle East and Africa

10.1 Middle East and Africa Radiopharmaceuticals by Countries

10.1.1 Middle East and Africa Radiopharmaceuticals Sales by Countries

10.1.2 Middle East and Africa Radiopharmaceuticals Revenue by Countries

10.1.3 GCC Countries

10.1.4 Turkey

10.1.5 Egypt

10.1.6 South Africa

10.2 Middle East and Africa Radiopharmaceuticals by Product

10.3 Middle East and Africa Radiopharmaceuticals by End User

11 Company Profiles

11.1 Bracco Imaging

11.1.1 Bracco Imaging Company Details

11.1.2 Company Business Overview

11.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)

11.1.4 Bracco Imaging Radiopharmaceuticals Products Offered

11.1.5 Bracco Imaging Recent Development

11.2 Bayer

11.2.1 Bayer Company Details

11.2.2 Company Business Overview

11.2.3 Bayer Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)

11.2.4 Bayer Radiopharmaceuticals Products Offered

11.2.5 Bayer Recent Development

11.3 Mallinckrodt

11.3.1 Mallinckrodt Company Details

11.3.2 Company Business Overview

11.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)

11.3.4 Mallinckrodt Radiopharmaceuticals Products Offered

11.3.5 Mallinckrodt Recent Development

11.4 Nordion

11.4.1 Nordion Company Details

11.4.2 Company Business Overview

11.4.3 Nordion Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)

11.4.4 Nordion Radiopharmaceuticals Products Offered

11.4.5 Nordion Recent Development

11.5 Triad Isotopes

11.5.1 Triad Isotopes Company Details

11.5.2 Company Business Overview

11.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)

11.5.4 Triad Isotopes Radiopharmaceuticals Products Offered

11.5.5 Triad Isotopes Recent Development

11.6 Lantheus

11.6.1 Lantheus Company Details

11.6.2 Company Business Overview

11.6.3 Lantheus Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)

11.6.4 Lantheus Radiopharmaceuticals Products Offered

11.6.5 Lantheus Recent Development

11.7 IBA Group

11.7.1 IBA Group Company Details

11.7.2 Company Business Overview

11.7.3 IBA Group Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)

11.7.4 IBA Group Radiopharmaceuticals Products Offered

11.7.5 IBA Group Recent Development

11.8 GE Healthcare

11.8.1 GE Healthcare Company Details

11.8.2 Company Business Overview

11.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)

11.8.4 GE Healthcare Radiopharmaceuticals Products Offered

11.8.5 GE Healthcare Recent Development

11.9 China Isotope & Radiation

11.9.1 China Isotope & Radiation Company Details

11.9.2 Company Business Overview

11.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)

11.9.4 China Isotope & Radiation Radiopharmaceuticals Products Offered

11.9.5 China Isotope & Radiation Recent Development

11.10 Jubilant Pharma

11.10.1 Jubilant Pharma Company Details

11.10.2 Company Business Overview

11.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue and Gross Margin (2014-2019)

11.10.4 Jubilant Pharma Radiopharmaceuticals Products Offered

11.10.5 Jubilant Pharma Recent Development

11.11 Eli Lilly

11.12 Advanced Accelerator Applications


11.14 Dongcheng

11.15 Navidea

12 Future Forecast

12.1 Radiopharmaceuticals Market Forecast by Regions

12.1.1 Global Radiopharmaceuticals Sales Forecast by Regions 2019-2025

12.1.2 Global Radiopharmaceuticals Revenue Forecast by Regions 2019-2025

12.2 Radiopharmaceuticals Market Forecast by Product

12.2.1 Global Radiopharmaceuticals Sales Forecast by Product 2019-2025

12.2.2 Global Radiopharmaceuticals Revenue Forecast by Product 2019-2025

12.3 Radiopharmaceuticals Market Forecast by End User

12.4 North America Radiopharmaceuticals Forecast

12.5 Europe Radiopharmaceuticals Forecast

12.6 Asia Pacific Radiopharmaceuticals Forecast

12.7 Central & South America Radiopharmaceuticals Forecast

12.8 Middle East and Africa Radiopharmaceuticals Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers

13.2 Market Challenges

13.3 Market Risks/Restraints

13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis

14.2 Radiopharmaceuticals Customers

14.3 Sales Channels Analysis

14.3.1 Sales Channels

14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer


Research Methodology


Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

The market engineered data is verified and validated by a number of experts, both in-house and external.

After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.